Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 374

1.

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Fröhling S, Utikal JS, von Kalle C; Collaborators.

Eur J Cancer. 2019 Mar 7;111:148-154. doi: 10.1016/j.ejca.2019.02.005. [Epub ahead of print]

2.

VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People.

Henderson LM, Robinson RF, Ray L, Li T, Dillard DA, Schilling BD, Mosley M, Janssen PL, Fohner AE, Rettie AE, Thummel KE, Thornton TA, Veenstra DL.

Clin Transl Sci. 2019 Mar 1. doi: 10.1111/cts.12611. [Epub ahead of print]

PMID:
30821933
3.

JNK modifies neuronal metabolism to promote proteostasis and longevity.

Wang L, Davis SS, Borch Jensen M, Rodriguez-Fernandez IA, Apaydin C, Juhasz G, Gibson BW, Schilling B, Ramanathan A, Ghaemmaghami S, Jasper H.

Aging Cell. 2019 Feb 27:e12849. doi: 10.1111/acel.12849. [Epub ahead of print]

4.

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.

Schilling B, Martens A, Geukes Foppen MH, Gebhardt C, Hassel JC, Rozeman EA, Gesierich A, Gutzmer R, Kähler KC, Livingstone E, Diamantopoulos PT, Gogas H, Madonna G, Ascierto PA, Goldinger SM, Mangana J, Garbe C, Schadendorf D, Blank C, Weide B.

Cancer Immunol Immunother. 2019 Feb 26. doi: 10.1007/s00262-019-02311-1. [Epub ahead of print]

PMID:
30806748
5.

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark.

Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, Karoglan A, von Kalle C, Weichenthal M, Sattler E, Schadendorf D, Gaiser MR, Klode J, Utikal JS.

Eur J Cancer. 2019 Feb 22;111:30-37. doi: 10.1016/j.ejca.2018.12.016. [Epub ahead of print]

6.

Global lysine acetylation in Escherichia coli results from growth conditions that favor acetate fermentation.

Schilling B, Basisty N, Christensen DG, Sorensen D, Orr JS, Wolfe AJ, Rao CV.

J Bacteriol. 2019 Feb 19. pii: JB.00768-18. doi: 10.1128/JB.00768-18. [Epub ahead of print]

PMID:
30782634
7.

Adipose Stem Cells Enhance Nerve Regeneration and Muscle Function In A Peroneal Nerve Ablation Model.

Passipieri JA, Dienes J, Frank J, Glazier J, Portell AJ, Venkatesh KP, Bliley JM, Grybowsky D, Schilling B, Marra K, Christ GJ.

Tissue Eng Part A. 2019 Feb 14. doi: 10.1089/ten.TEA.2018.0244. [Epub ahead of print]

PMID:
30760135
8.

Injectable Allograft Adipose Matrix Supports Adipogenic Tissue Remodeling in the Nude Mouse and Human.

Kokai LE, Schilling BK, Chnari E, Huang YC, Imming EA, Karunamurthy A, Khouri RK, D'Amico RA, Coleman SR, Marra KG, Rubin JP.

Plast Reconstr Surg. 2019 Feb;143(2):299e-309e. doi: 10.1097/PRS.0000000000005269.

9.

Adipose-derived stem cells delay muscle atrophy after peripheral nerve injury in the rodent model.

Schilling BK, Schusterman MA 2nd, Kim DY, Repko AJ, Klett KC, Christ GJ, Marra KG.

Muscle Nerve. 2019 Jan 25. doi: 10.1002/mus.26432. [Epub ahead of print]

PMID:
30681163
10.

Solid phase microextraction Arrow for the determination of synthetic musk fragrances in fish samples.

Castro Ó, Trabalón L, Schilling B, Borrull F, Pocurull E.

J Chromatogr A. 2019 Jan 11. pii: S0021-9673(19)30047-0. doi: 10.1016/j.chroma.2019.01.032. [Epub ahead of print]

PMID:
30658910
11.

Tackling melanoma by adjuvant therapy: why, whom and how?

Schilling B, Wiesner T.

Br J Dermatol. 2019 Jan;180(1):1-2. doi: 10.1111/bjd.17039. No abstract available.

PMID:
30604551
12.

Temporal dynamics of liver mitochondrial protein acetylation and succinylation and metabolites due to high fat diet and/or excess glucose or fructose.

Meyer JG, Softic S, Basisty N, Rardin MJ, Verdin E, Gibson BW, Ilkayeva O, Newgard CB, Kahn CR, Schilling B.

PLoS One. 2018 Dec 26;13(12):e0208973. doi: 10.1371/journal.pone.0208973. eCollection 2018.

13.

The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.

Appenzeller S, Gesierich A, Thiem A, Hufnagel A, Jessen C, Kneitz H, Regensburger M, Schmidt C, Zirkenbach V, Bischler T, Schilling B, Siedel C, Goebeler ME, Houben R, Schrama D, Gehrig A, Rost S, Maurus K, Bargou R, Rosenwald A, Schartl M, Goebeler M, Meierjohann S.

Cancer. 2019 Feb 15;125(4):586-600. doi: 10.1002/cncr.31843. Epub 2018 Dec 18.

PMID:
30561760
14.

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.

Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, Ashenberg O, Ott PA, Buchbinder EI, Haq R, Hodi FS, Boland GM, Sullivan RJ, Frederick DT, Miao B, Moll T, Flaherty KT, Herlyn M, Jenkins RW, Thummalapalli R, Kowalczyk MS, Cañadas I, Schilling B, Cartwright ANR, Luoma AM, Malu S, Hwu P, Bernatchez C, Forget MA, Barbie DA, Shalek AK, Tirosh I, Sorger PK, Wucherpfennig K, Van Allen EM, Schadendorf D, Johnson BE, Rotem A, Rozenblatt-Rosen O, Garraway LA, Yoon CH, Izar B, Regev A.

Cell. 2018 Nov 1;175(4):984-997.e24. doi: 10.1016/j.cell.2018.09.006.

PMID:
30388455
15.

Identification of Novel Protein Lysine Acetyltransferases in Escherichia coli.

Christensen DG, Meyer JG, Baumgartner JT, D'Souza AK, Nelson WC, Payne SH, Kuhn ML, Schilling B, Wolfe AJ.

MBio. 2018 Oct 23;9(5). pii: e01905-18. doi: 10.1128/mBio.01905-18.

16.

Identifying ubiquitinated proteins and aggregates.

Basisty N, Schilling B, Rabinovitch PS.

Aging (Albany NY). 2018 Oct 18;10(10):2549-2550. doi: 10.18632/aging.101605. No abstract available.

17.

Programmed death-1 blockade for multiple basal cell carcinomas: clearing the field systemically?

Haug V, Schilling B.

Br J Dermatol. 2018 Sep;179(3):566-567. doi: 10.1111/bjd.16991. No abstract available.

PMID:
30222888
18.

Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment.

Pieper N, Zaremba A, Leonardelli S, Harbers FN, Schwamborn M, Lübcke S, Schrörs B, Baingo J, Schramm A, Haferkamp S, Seifert U, Sucker A, Lennerz V, Wölfel T, Schadendorf D, Schilling B, Paschen A, Zhao F.

Oncoimmunology. 2018 Apr 18;7(8):e1450127. doi: 10.1080/2162402X.2018.1450127. eCollection 2018.

PMID:
30221038
19.

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors.

Miao D, Margolis CA, Vokes NI, Liu D, Taylor-Weiner A, Wankowicz SM, Adeegbe D, Keliher D, Schilling B, Tracy A, Manos M, Chau NG, Hanna GJ, Polak P, Rodig SJ, Signoretti S, Sholl LM, Engelman JA, Getz G, Jänne PA, Haddad RI, Choueiri TK, Barbie DA, Haq R, Awad MM, Schadendorf D, Hodi FS, Bellmunt J, Wong KK, Hammerman P, Van Allen EM.

Nat Genet. 2018 Sep;50(9):1271-1281. doi: 10.1038/s41588-018-0200-2. Epub 2018 Aug 27.

20.

Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation.

Bruning U, Morales-Rodriguez F, Kalucka J, Goveia J, Taverna F, Queiroz KCS, Dubois C, Cantelmo AR, Chen R, Loroch S, Timmerman E, Caixeta V, Bloch K, Conradi LC, Treps L, Staes A, Gevaert K, Tee A, Dewerchin M, Semenkovich CF, Impens F, Schilling B, Verdin E, Swinnen JV, Meier JL, Kulkarni RA, Sickmann A, Ghesquière B, Schoonjans L, Li X, Mazzone M, Carmeliet P.

Cell Metab. 2018 Dec 4;28(6):866-880.e15. doi: 10.1016/j.cmet.2018.07.019. Epub 2018 Aug 23.

PMID:
30146486
21.

Preclinical Optimization of a Shelf-Ready, Injectable, Human-Derived, Decellularized Allograft Adipose Matrix.

Giatsidis G, Succar J, Haddad A, Lago G, Schaffer C, Wang X, Schilling B, Chnari E, Matsumine H, Orgill DP.

Tissue Eng Part A. 2019 Feb;25(3-4):271-287. doi: 10.1089/ten.TEA.2018.0052. Epub 2018 Oct 16.

PMID:
30084731
22.

Simultaneous Quantification of the Acetylome and Succinylome by 'One-Pot' Affinity Enrichment.

Basisty N, Meyer JG, Wei L, Gibson BW, Schilling B.

Proteomics. 2018 Sep;18(17):e1800123. doi: 10.1002/pmic.201800123. Epub 2018 Aug 19.

23.

Nocardiosis in a patient with anti-PD-1-associated colitis treated with infliximab.

Glutsch V, Gesierich A, Goebeler M, Forster J, Schilling B.

Eur J Cancer. 2018 Sep;101:284-286. doi: 10.1016/j.ejca.2018.06.014. Epub 2018 Jul 13. No abstract available.

PMID:
30017385
24.

Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.

Milsch L, Gesierich A, Kreft S, Livingstone E, Zimmer L, Goebeler M, Schadendorf D, Schilling B.

Eur J Cancer. 2018 Aug;99:58-65. doi: 10.1016/j.ejca.2018.05.012. Epub 2018 Jun 12.

PMID:
29906735
25.

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.

Kugel CH 3rd, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, Svoronos N, Kumar V, Wang DY, Somasundaram R, Hu-Lieskovan S, Ozgun A, Herlyn M, Conejo-Garcia JR, Gabrilovich D, Stone EL, Nowicki TS, Sosman J, Rai R, Carlino MS, Long GV, Marais R, Ribas A, Eroglu Z, Davies MA, Schilling B, Schadendorf D, Xu W, Amaravadi RK, Menzies AM, McQuade JL, Johnson DB, Osman I, Weeraratna AT.

Clin Cancer Res. 2018 Nov 1;24(21):5347-5356. doi: 10.1158/1078-0432.CCR-18-1116. Epub 2018 Jun 13.

PMID:
29898988
26.

Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors.

Thiem A, Schummer P, Ueberschaar S, Kerstan A, Kneitz H, Schrama D, Appenzeller S, Meierjohann S, Schilling B, Goebeler M, Gesierich A.

Melanoma Res. 2018 Oct;28(5):465-468. doi: 10.1097/CMR.0000000000000458.

PMID:
29781871
27.

Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma.

Haug V, Behle V, Benoit S, Kneitz H, Schilling B, Goebeler M, Gesierich A.

Br J Dermatol. 2018 Oct;179(4):993-994. doi: 10.1111/bjd.16780. Epub 2018 Jul 23. No abstract available.

PMID:
29758087
28.

Biodegradable silk catheters for the delivery of therapeutics across anatomical repair sites.

Brown JE, Tozzi L, Schilling B, Kelmendi-Doko A, Truong AB, Rodriguez MJ, Gil ES, Sucsy R, Valentin JE, Philips BJ, Marra KG, Rubin JP, Kaplan DL.

J Biomed Mater Res B Appl Biomater. 2019 Apr;107(3):501-510. doi: 10.1002/jbm.b.34140. Epub 2018 Apr 26.

PMID:
29697188
30.

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

Shukla SA, Bachireddy P, Schilling B, Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D, Keskin DB, Babadi M, Mohammad A, Gnirke A, Clement K, Cartun ZJ, Van Allen EM, Miao D, Huang Y, Snyder A, Merghoub T, Wolchok JD, Garraway LA, Meissner A, Weber JS, Hacohen N, Neuberg D, Potts PR, Murphy GF, Lian CG, Schadendorf D, Hodi FS, Wu CJ.

Cell. 2018 Apr 19;173(3):624-633.e8. doi: 10.1016/j.cell.2018.03.026. Epub 2018 Apr 12.

PMID:
29656892
31.

Removing 4E-BP Enables Synapses to Refine without Postsynaptic Activity.

Chong Y, Saviuk N, Pie B, Basisty N, Quinn RK, Schilling B, Sonenberg N, Cooper E, Haghighi AP.

Cell Rep. 2018 Apr 3;23(1):11-22. doi: 10.1016/j.celrep.2018.03.040.

32.

NF1 mutations in conjunctival melanoma.

Scholz SL, Cosgarea I, Süßkind D, Murali R, Möller I, Reis H, Leonardelli S, Schilling B, Schimming T, Hadaschik E, Franklin C, Paschen A, Sucker A, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG.

Br J Cancer. 2018 May;118(9):1243-1247. doi: 10.1038/s41416-018-0046-5. Epub 2018 Mar 21.

PMID:
29559732
33.

Panorama Public: A Public Repository for Quantitative Data Sets Processed in Skyline.

Sharma V, Eckels J, Schilling B, Ludwig C, Jaffe JD, MacCoss MJ, MacLean B.

Mol Cell Proteomics. 2018 Jun;17(6):1239-1244. doi: 10.1074/mcp.RA117.000543. Epub 2018 Feb 27.

PMID:
29487113
34.

Kinetic and Electromyographic Subphase Characteristics With Relation to Countermovement Vertical Jump Performance.

Harry JR, Paquette MR, Schilling BK, Barker LA, James CR, Dufek JS.

J Appl Biomech. 2018 Aug 1;34(4):291-297. doi: 10.1123/jab.2017-0305. Epub 2018 Jul 3.

PMID:
29485344
35.

Protein Turnover in Aging and Longevity.

Basisty N, Meyer JG, Schilling B.

Proteomics. 2018 Mar;18(5-6):e1700108. doi: 10.1002/pmic.201700108. Review.

36.

Cytochrome P450 Genetic Variation Associated with Tamoxifen Biotransformation in American Indian and Alaska Native People.

Khan BA, Robinson R, Fohner AE, Muzquiz LI, Schilling BD, Beans JA, Olnes MJ, Trawicki L, Frydenlund H, Laukes C, Beatty P, Phillips B, Nickerson D, Howlett K, Dillard DA, Thornton TA, Thummel KE, Woodahl EL.

Clin Transl Sci. 2018 May;11(3):312-321. doi: 10.1111/cts.12542. Epub 2018 Feb 13.

37.

Potential Utility of a Loaded Treadmill Protocol for Tactical Athletes.

Swearingen JT, Weiss LW, Smith WA, Stephenson MD, Schilling BK.

J Strength Cond Res. 2018 Mar;32(3):610-616. doi: 10.1519/JSC.0000000000002217.

PMID:
29189586
38.

Ancient Regulatory Role of Lysine Acetylation in Central Metabolism.

Nakayasu ES, Burnet MC, Walukiewicz HE, Wilkins CS, Shukla AK, Brooks S, Plutz MJ, Lee BD, Schilling B, Wolfe AJ, Müller S, Kirby JR, Rao CV, Cort JR, Payne SH.

MBio. 2017 Nov 28;8(6). pii: e01894-17. doi: 10.1128/mBio.01894-17.

39.

Can checkpoint inhibitor therapy improve response to chemotherapy?

Kirchberger MC, Schilling B, Haferkamp S, Bosserhoff A, Schuler G, Heinzerling L.

J Cancer Res Clin Oncol. 2018 Jan;144(1):183-185. doi: 10.1007/s00432-017-2546-8. Epub 2017 Nov 24. No abstract available.

PMID:
29177557
40.

An acetylatable lysine controls CRP function in E. coli.

Davis R, Écija-Conesa A, Gallego-Jara J, de Diego T, Filippova EV, Kuffel G, Anderson WF, Gibson BW, Schilling B, Canovas M, Wolfe AJ.

Mol Microbiol. 2018 Jan;107(1):116-131. doi: 10.1111/mmi.13874. Epub 2017 Nov 23.

PMID:
29105190
41.

Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis.

Franklin C, Rooms I, Fiedler M, Reis H, Milsch L, Herz S, Livingstone E, Zimmer L, Schmid KW, Dittmer U, Schadendorf D, Schilling B.

Eur J Cancer. 2017 Nov;86:248-256. doi: 10.1016/j.ejca.2017.09.019. Epub 2017 Oct 19.

PMID:
29055840
42.

Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates.

Post DMB, Slütter B, Schilling B, Chande AT, Rasmussen JA, Jones BD, D'Souza AK, Reinders LM, Harty JT, Gibson BW, Apicella MA.

MBio. 2017 Oct 10;8(5). pii: e01592-17. doi: 10.1128/mBio.01592-17.

43.

Membrane Processes.

Pellegrin ML, Arabi S, Aguinaldo J, Sadler ME, Greiner AD, Padhye LP, Burbano MS, Wong J, Kent F, Dow A, Danker B, Diamond J, Sadreddini S, McCandless R, Tootchi L, Schilling B, Kinser K.

Water Environ Res. 2017 Oct 1;89(10):1066-1135. doi: 10.2175/106143017X15023776270241. Review.

PMID:
28954654
44.

Notch/Her12 signalling modulates, motile/immotile cilia ratio downstream of Foxj1a in zebrafish left-right organizer.

Tavares B, Jacinto R, Sampaio P, Pestana S, Pinto A, Vaz A, Roxo-Rosa M, Gardner R, Lopes T, Schilling B, Henry I, Saúde L, Lopes SS.

Elife. 2017 Sep 6;6. pii: e25165. doi: 10.7554/eLife.25165.

45.

Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.

Collins BC, Hunter CL, Liu Y, Schilling B, Rosenberger G, Bader SL, Chan DW, Gibson BW, Gingras AC, Held JM, Hirayama-Kurogi M, Hou G, Krisp C, Larsen B, Lin L, Liu S, Molloy MP, Moritz RL, Ohtsuki S, Schlapbach R, Selevsek N, Thomas SN, Tzeng SC, Zhang H, Aebersold R.

Nat Commun. 2017 Aug 21;8(1):291. doi: 10.1038/s41467-017-00249-5.

46.

Noninvasive Assessment of Skeletal Muscle Myosin Heavy Chain Expression in Trained and Untrained Men.

Fry AC, Housh TJ, Cramer JB, Weir JP, Beck TW, Schilling BK, Miller JD, Nicoll JX.

J Strength Cond Res. 2017 Sep;31(9):2355-2362. doi: 10.1519/JSC.0000000000001645.

PMID:
28820846
47.

Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.

Thiem A, Kneitz H, Schummer P, Herz S, Schrama D, Houben R, Goebeler M, Schilling B, Gesierich A.

Acta Derm Venereol. 2017 Nov 15;97(10):1252-1254. doi: 10.2340/00015555-2757. No abstract available.

48.

Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.

Scholz SL, Möller I, Reis H, Süßkind D, van de Nes JAP, Leonardelli S, Schilling B, Livingstone E, Schimming T, Paschen A, Sucker A, Murali R, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3464-3470. doi: 10.1167/iovs.17-21838.

PMID:
28700778
49.

PIQED: automated identification and quantification of protein modifications from DIA-MS data.

Meyer JG, Mukkamalla S, Steen H, Nesvizhskii AI, Gibson BW, Schilling B.

Nat Methods. 2017 Jun 29;14(7):646-647. doi: 10.1038/nmeth.4334. No abstract available.

50.

Identification and characterization of AckA-dependent protein acetylation in Neisseria gonorrhoeae.

Post DMB, Schilling B, Reinders LM, D'Souza AK, Ketterer MR, Kiel SJ, Chande AT, Apicella MA, Gibson BW.

PLoS One. 2017 Jun 27;12(6):e0179621. doi: 10.1371/journal.pone.0179621. eCollection 2017.

Supplemental Content

Loading ...
Support Center